Delivery Order SPE2DB20D3303-SPE2DB25FA3KG
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,090.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed-price delivery order is non-competitive and represents a single shipment of the diabetes and weight management medication to support federal healthcare requirements. The contract will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,308.60 for Zepbound 10 mg/0.5 ml pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a procurement of the injectable diabetes medication under the DLA's pharmaceutical...
- The Defense Logistics Agency awarded a $22,539.19 firm fixed price delivery order to AmerisourceBergen Drug Corp for 5 mg/0.5 mL Zepbound pens on September 3, 2025, with completion scheduled for September 4, 2025. This non-set-aside contract represents a single delivery order for the diabetes medication under the company's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,875.36 for Zepbound 10 mg/0.5 ml pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract, executed without a set-aside designation, represents a competitive award to the pharmaceutical distributor for diabetes medication supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the federal...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,596.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen (0.5 mL) on July 28, 2025. This is a firm fixed price, non-set-aside delivery order that will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. The contract represents a single delivery of this diabetes treatment medication to support federal medical procurement needs. This delivery order falls...
- The Defense Logistics Agency awarded a $1,507.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract represents a small-value delivery order for the diabetes and weight management medication under the company's larger pharmaceutical supply agreement with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the...
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $3,115.90 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen (0.5 ml), a pharmaceutical product used in diabetes and weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,360.72 for Zepbound 7.5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $88,265.10 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $4,273.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with an ultimate completion date of August 18, 2025. This is a non-set-aside competitive award leveraging AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that runs through December 2026....